Antibiotice S.A. (BVB: ATB)
Health Care · Pharmaceuticals · RO
RON2.11
-1.40% today · -15.3% 1Y
Antibiotice S.A. (BVB: ATB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $314.85M.
Over the last twelve months the share price has lost 15.3%, trading between 1.75 and 2.64.
Tweenvest scores Antibiotice S.A. across four factors: quality 71/100, value 33/100, growth 48/100, dividend 19/100. Its strongest factor is quality.
ATB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $314.85M
- Revenue (TTM)
- $134.43M
- P/E
- 174.11
- EPS
- 0.01
- Dividend yield
- 1.70%
- Beta (5Y)
- 0.23
- 52-week high
- RON2.64
- 52-week low
- RON1.75
- Avg volume (3M)
- —
- Shares outstanding
- 671.34M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.